101 related articles for article (PubMed ID: 2133252)
1. Tyrosine kinase blockers: new platelet activation inhibitors.
Rendu F; Eldor A; Grelac F; Levy-Toledano S; Levitzki A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
[TBL] [Abstract][Full Text] [Related]
2. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
3. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
Nakashima S; Koike T; Nozawa Y
Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
[TBL] [Abstract][Full Text] [Related]
4. The effects of tyrphostins B42 and B46 on equine platelet function and protein tyrosine phosphorylation.
Dillon AM; Heath MF
Biochem Biophys Res Commun; 1995 Jul; 212(2):595-601. PubMed ID: 7542881
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
Martinson EA; Scheible S; Presek P
Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet activation by tyrosine kinase inhibitors.
Rendu F; Eldor A; Grelac F; Bachelot C; Gazit A; Gilon C; Levy-Toledano S; Levitzki A
Biochem Pharmacol; 1992 Sep; 44(5):881-8. PubMed ID: 1382425
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
Diaz-Ricart M; Palomo M; Fuste B; Lopez-Vilchez I; Carbo C; Perez-Pujol S; White JG; Escolar G
Thromb Res; 2008; 121(6):873-83. PubMed ID: 17904203
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein.
Wong S; Reynolds AB; Papkoff J
Oncogene; 1992 Dec; 7(12):2407-15. PubMed ID: 1281303
[TBL] [Abstract][Full Text] [Related]
9. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
Koda M; Banno Y; Naganawa T
Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
[TBL] [Abstract][Full Text] [Related]
10. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
Rendu F; Bachelot C; Molle D; Caen J; Guez D
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen.
Hargreaves PG; Licking EF; Sargeant P; Sage SO; Barnes MJ; Farndale RW
Thromb Haemost; 1994 Oct; 72(4):634-42. PubMed ID: 7878644
[TBL] [Abstract][Full Text] [Related]
12. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
14. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
[TBL] [Abstract][Full Text] [Related]
16. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA
Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958
[TBL] [Abstract][Full Text] [Related]
17. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thrombin-induced platelet activation by dioctanoylglycerol pretreatment is not correlated with the 47 kDa protein phosphorylation.
Ruzzene M; Francesconi M; Cavallini L; Battistella L; Deana R
Second Messengers Phosphoproteins; 1992; 14(1-2):11-9. PubMed ID: 1403847
[TBL] [Abstract][Full Text] [Related]
19. The effects of 1-oleoyl-2-acetylglycerol on platelet protein phosphorylation and platelet ultrastructure.
Friesen LL; Gerrard JM
Am J Pathol; 1985 Oct; 121(1):79-87. PubMed ID: 4050978
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.
Asahi M; Yanagi S; Ohta S; Inazu T; Sakai K; Takeuchi F; Taniguchi T; Yamamura H
FEBS Lett; 1992 Aug; 309(1):10-4. PubMed ID: 1511739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
